Abstract:Melittin (M) has attracted increasing attention for its significant antitumor effects and various immunomodu-latory effects. However, various obstacles such as the short plasma half-life and adverse reactions restrict its application. This study aimed to systematically investigate the self-assembly mechanism, components of the protein corona, targeting behavior, and anti-4 T1 tumor effect of vitamin E-succinic acid-(glutamate)n /melittin nanoparticles with varying amounts of glutamic acid. Here, we present a new vitamin E-succinic acid-(gluta-mate)5 (E5), vitamin E-succinic acid-(glutamate)10 (E10) or vitamin E-succinic acid-(glutamate)15 (E15), and their co-assembly system with positively charged melittin in water. The molecular dynamics simulations demonstrated that the electrostatic energy and van der Waals force in the system decreased significantly with the increase in the amount of glutamic acid. The melittin and E15 system exhibited the optimal stability for nanoparticle self-assembly. When nanoparticles derived from different self-assembly systems were co-incubated with plasma from patients with breast cancer, the protein corona showed heterogeneity. In vivo imaging demonstrated that an increase in the number of glutamic acid residues enhanced circulation duration and tumor-targeting effects. Both in vitro and in vivo antitumor evaluation indicated a significant increase in the antitumor effect with the addition of glutamic acid. According to our research findings, the number of glutamic acid residues plays a crucial role in the targeted delivery of melittin for immunomodulation and inhibition of 4 T1 breast cancer. Due to the self-assembly capabilities of vitamin E-succinic acid-(glutamate)n in water, these nanoparticles carry significant potential for delivering cationic peptides such as melittin.

Determining the Effect of Non-Thermal Plasma on the Transmembrane Kinetics of Melittin through Molecular Explorations

Non-thermal Plasma-Treated Melatonin Inhibits the Biological Activity of HCC Cells by Increasing Intracellular ROS Levels and Reducing RRM2 Expression.

Melittin-Based Nano-Delivery Systems for Cancer Therapy

Metal–Phenolic Network-Facilitated “Foe-to-Friend” Conversion of Melittin for Cancer Immunotherapy with Boosted Abscopal Effect

Stable Loading and Delivery of Melittin with Lipid-Coated Polymeric Nanoparticles for Effective Tumor Therapy with Negligible Systemic Toxicity

Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies

Turning Toxicants into Safe Therapeutic Drugs: Cytolytic Peptide−Photosensitizer Assemblies for Optimized In Vivo Delivery of Melittin

Non‑thermal Plasma Inhibits Tumor Growth and Proliferation and Enhances the Sensitivity to Radiation in Vitro and in Vivo.

Nanoscale Melittin@Zeolitic Imidazolate Frameworks for Enhanced Anticancer Activity and Mechanism Analysis.

Molecular Dynamics Simulation of the Transmembrane Transport Process of Reactive Species under the Synergistic Effect of Plasma Oxidation and an Electric Field.

Glutamate Affects Self-Assembly, Protein Corona, and Anti-4 T1 Tumor Effects of Melittin/vitamin E-succinic Acid-(Glutamate)n Nanoparticles

Melittin-incorporated nanomedicines for enhanced cancer immunotherapy

Hybrid Melittin Cytolytic Peptide-Driven Ultrasmall Lipid Nanoparticles Block Melanoma Growth <i>in Vivo</i>

Melatonin Potentiates “Inside-Out” Nano-Thermotherapy in Human Breast Cancer Cells: a Potential Cancer Target Multimodality Treatment Based on Melatonin-Loaded Nanocomposite Particles

Selective effects of non-thermal atmospheric plasma on triple-negative breast normal and carcinoma cells through different cell signaling pathways

Hybrid melittin cytolytic Peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo.

Microscopic mechanistic study of the penetration distributions for plasma reactive oxygen and nitrogen species based on sialic acid targeting on the cell membrane surface

Antitumor effects of plasma‐activated solution on a murine melanoma model in vivo and in vitro

Homologous-targeting biomimetic nanoparticles co-loaded with melittin and a photosensitizer for the combination therapy of triple negative breast cancer

Magnetic nanoparticles and possible synergies with cold atmospheric plasma for cancer treatment

Nitric Oxide Synergistic Microwave Via Amplification of Immunogenic Cell Death for Enhanced Tumor Thermotherapy